Kodiak Sciences Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows investor participation in company decisions through voting at the annual shareholder meeting.
Reveals how the company performed financially in the first three months of 2026.
Reveals how the company performed financially in the first three months of 2026.
Explains how the company is run, who leads it, and how executives are paid.
Shows how Kodiak Sciences performed throughout the entire year 2025.
Positive test results for a drug candidate could lead to future sales and approval.
Stocky reads Kodiak Sciences Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Kodiak Sciences Inc.'s most recent tracked filing was a 8-K on 4 Jun 2026: Stockholders vote at 2026 annual meeting with 88.53% attendance.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.